This pitch about “Federal Rent Checks” has been circulating for quite a while, and it’s still being mailed out with a July 2018 date under the signature (I got a few questions about it just this week), so I decided to take a second look. And what do you know, there has been a LOT […]
Articles
This is the little ad snippet that sent me down a rabbit hole today: “The $10 Company at the Center of a Revolution: It’s inked four deals with huge players in its sector, and it’s holding the keys to a potential global product. Click here to learn more…” It led to an ad titled “The […]
Today we’re going back to the vault to open an older Friday File article up for everyone, since the ad I was writing about in December appears to again be circulating today. This one’s about a teaser that’s being foist upon the world by Bill pantaloon at Money Map about a “gold anomaly.” I have […]
Here’s what caught our readers’ attention in a pitch from Bill Patalon’s Private Briefing: “Early investors could reap as much as $115,900 beginning April 21 “In the barren, hostile plains of the New Mexico desert, not far from the Mexican border, they’re building a city like no other. “A city with high rises, avenues, parks, […]
Today we’ve broken the Friday File up into two parts for your convenience — part one is all about a couple high-dividend technology stocks that look appealing to me right now, including one I bought a bit more of recently, and this one’s about a teaser that’s being foist upon the world by Bill pantaloon […]
A few sharp-eyed readers have asked about a teaser ad now circulating from Bill Patalon, and that headline is taken from the ad — a few other stocks are teased as hot “secret” recommendations of Patalon’s Private Briefing service, but it’s that “biggest medical breakthrough of the decade” bit that seems to be catching the […]
This ad is a re-hashing of a recommendation that Bill Patalon’s Private Briefing was touting back in October of 2015 — so I’m re-publishing the piece below so you can see the details about the company. It has not been updated or revised since 10/30/15. The ad has changed considerably since last Fall — back […]
[ed. note: This article originally ran on October 6, 2015. The ad is circulating again and generating questions here at Stock Gumshoe, and it appears unchanged. The article that follows is also unchanged and has not been updated. The stock being teased by Money Morning is essentially unchanged in price from when this article was […]
Every year, I scroll through the last twelve months or so of teaser picks and look for one that really stands out as the stinker of the bunch, to be called the Turkey of the Year and hold that place of honor at Thanksgiving time. Hopefully, we can all give thanks that we didn’t own […]
This ad about a “Donald Trump investment” is sending a lot of questions our way, so we’re going to take a look at it for you in today’s Friday File… and I’ve also got an update on Sandstorm Gold to share, plus a quick look at the idea of “protection” from market declines and how […]
This is one of the shorter teaser pitches I’ve ever covered — so, bonus for you, it’s also likelier to be one of my shorter articles! The spiel is an ad for Bill Patalon’s Private Briefing, which is one of those “greatest hits” newsletters … it’s intended to cherry-pick the “best” ideas from all the […]
I haven’t looked at a teaser pitch from Private Briefing for a while, that’s the “pay as you go” monthly newsletter from Bill Patalon at Money Map Press — in the interim, the it looks like the price has just about tripled to $19.99 a month (that’s $239.88 a year for those who are math […]
There have been two pretty big promo campaigns about the Alibaba IPO in the last week or so — one from Bill Patalon in an ad for his Private Briefing, and the other from Mike Palmer for Jeff Clark’s S&A Short Report… so I thought we should try to take a look, answer some reader […]
“Yesterday, I sent you an urgent briefing regarding China’s dangerous “Internet Army.” This situation is already moving fast. “The small tech company critical to crushing China’s attacks just won another contract for an undisclosed “data center”… its third multimillion-dollar contract in less than a month. “This is quickly turning into exactly the kind of win-win […]
“I Have Access to Financial Strategies That You Don’t Have… “And They Could Be Worth a Fortune “Starting with the Next 295% Extravaganza… “I just discovered a large, sudden and concentrated block of insider buying. “Please… pay attention to this… “I’m talking about 7 insiders, including the CEO and CFO. They just spent $353,000 on […]
Monthly “pay as you go” subscription to the publisher’s pick of stock ideas from Money Map Press editors.
Comments
Finally worked out for hopeful PACB shareholders... as long as you didn't buy during late 2015 or 2016. I have no idea ...
No, they sell DNA sequencing equipment... you can’t edit what you don’t know, eh? Folks have pitched ILMN as a “...
Hank, The biotech stocks are too risky for me as I do not understand the market and do not have any contacts/references...
$MOTELY Fool's top 4 BIO Pics for 2018. Just got a teaser ad for the MF Explorer investment newsletter. They are nomin...
$GNMX: Hello Everyone, I wanted to share this pertinent ADHD article on Genome-wide Copy Number Verification (CNV) map...
I don't know if this article from Fierce Biotech of Jan 18 has been mentioned in reference to $BIOC (long). Bio-Rad h...
2016 Illumina spinout, Grail, apparently raised $100 million in Series A financing from Bill Gates, Amazon founder Jeff...
A class action suit was filed against the company on Dec. 16, 2016, one in NY, one in the U.S. District Court for the So...
Forgot to mention, no position in Genfit, Merck, or Illumina....
Illumina Again Preannounces Q3 Revenue Shortfall; Shares Plunge Gene sequencer Illumina (ILMN) preannounced a Q3...
$TMO, ILMN np: Illumina (ILMN) Stock Gains on Thermo Fisher Takeover Speculation Thermo Fisher Scientific (TMO) has re...
$ILMN no position - A bit off topic for our west coast folks: Illumina To Produce Genome Sequencer For California Mark...
Illumina or Match is the stock Motley is hinting at?...
I called them up and was told it was Illumina...
The Gardner double down is ilmm illumina, the San Diego based genetic sequencing giant. ilmm has just created Grail, a ...
Hey Ben, Dr. Skousen said by Cubist Pharmacuticals at $12.00 and at its high I think it was around $68.00, now its hoove...
I own Illumina (a US share) and Thermo Fisher (a US share) for one simple reason: I couldn't find any ADRs with the same...
Maybe a little competition for Illumina. http://www.forbes.com/sites/luketimmerman/2015/01/12/stealthy-10x-genomics-rai...
Is this an interesting "pick and shovel play" in the biotech sector? Basically personalized medicine via genetics? Acc...
I subscribe to the magazine MIT Technology Review. On the cover of the current issue 'The Smartest Company in the World ...
The first one is Illumina, Inc. (ILMN). Last year Revenue $902 million and net income $124,891,000. Net income in 2008 w...
I love the gene sequencing idea. Illumina has had some success, but there are many new technologies. There are very many...
What a fantastic article. After reading the Motley Fool report, I analyzed many of same stocks mentioned here, and I ha...